3DPrint.com March 7, 2024
Joris Peels

BellaSeno, already exploring significant opportunities with its custom resorbable breast implants entering clinical trials, is expanding its scope. The company has received market approval for its bone scaffold product and is venturing beyond its initial focus. It highlights a case where its resorbable scaffolds were utilized in a trauma situation, specifically for a patient with an infected radial shaft resulting from a bullet wound. This case has been documented in the Journal of Personalized Medicine, indicating the company’s commitment to diversifying its applications in medical treatments.

A team at Hannover Medical School‘s Clinic for Trauma Surgery created a custom scaffold to aid in the healing of a patient’s arm. This patient had previously undergone over six surgeries to repair the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: 3D Printing, Health System / Hospital, Provider, Technology
Technologies Transforming the Surgical Experience
WASP Highlights Advances in Healthcare 3D Printing at Italy’s Exposanità 2024
3D Systems Brings 3D Printed PEEK Cranial Implant to the U.S. with FDA Clearance
3D Printing Market Hits $14.7B Amid Challenges in 2023
World’s First Bioprinted Trachea Transplant Marks a New Era in Medical Innovation

Share This Article